Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 148,137	$ 38,241
Restricted cash	244,625	256,237
Derivatives	16,867	17,958
Prepaid expenses and other current assets	2,943	2,089
Total current assets	412,572	314,525
Property, plant and equipment, net	5,020,003	2,437,733
Operating lease right-of-use assets	166,082	170,827
Deferred financing fees	317,788	389,695
Derivatives	472,057	0
Other non-current assets	15,557	11,021
Total assets	6,404,059	3,323,801
Current liabilities:
Accounts payable	244,642	243,129
Operating lease liabilities	2,881	3,143
Accrued and other current liabilities	347,561	306,115
Total current liabilities	595,084	552,387
Operating lease liabilities	144,164	145,962
Derivative liability	0	66,899
Debt, net	3,920,425	1,816,301
Other non-current liabilities	0	1,818
Total liabilities	4,659,673	2,583,367
Commitments and contingencies (Note 13 )
Equity:
Common stock, $0.0001 par value, 480.0 million authorized: 260.2 million and 256.5 million outstanding, respectively	26	26
Treasury stock: 3.1 million and 2.2 million respectively, at cost	(20,916)	(14,214)
Preferred stock, $0.0001 par value, 0.5 million authorized after designation of the convertible preferred stock: none outstanding	0	0
Additional paid-in-capital	852,054	693,883
Accumulated deficit	(453,523)	(391,772)
Total stockholders' equity	377,641	287,923
Non-controlling interest	1,366,745	452,511
Total equity	1,744,386	740,434
Total liabilities and equity	$ 6,404,059	$ 3,323,801